Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Decreased risk of rheumatic skin diseases in HIV/AIDS inpatients.
Ji-Xu A, Lei D, Nguyen K, Yang J, Erickson M, Cheng K, Worswick S, Maloney N. Ji-Xu A, et al. Clin Exp Dermatol. 2022 Oct;47(10):1860-1861. doi: 10.1111/ced.15244. Epub 2022 Jun 6. Clin Exp Dermatol. 2022. PMID: 35486675 No abstract available.
Omalizumab as adjuvant therapy for pemphigus vulgaris.
Ji-Xu A, Artounian K, Fung MA, Le ST, Maverakis E. Ji-Xu A, et al. Dermatol Ther. 2022 Aug;35(8):e15646. doi: 10.1111/dth.15646. Epub 2022 Jun 29. Dermatol Ther. 2022. PMID: 35716013 No abstract available.
Clinicopathological characteristics of individuals with coexisting melanoma and chronic lymphocytic leukaemia: a multicentre cohort study.
Fisher RM, Ji-Xu A, Abbott R, Basu T, Brown A, Foley C, Glen C, Gupta G, Hasan Z, Ismail F, Khalid A, Khoo ABS, Koumaki D, Lally A, Lear JT, McGrath EJ, McKenna K, Milligan A, Mulholland O, Tasker F, Harwood CA, Proby CM, Matin RN. Fisher RM, et al. Clin Exp Dermatol. 2022 Nov;47(11):1976-1981. doi: 10.1111/ced.15324. Epub 2022 Sep 9. Clin Exp Dermatol. 2022. PMID: 35801421
Proprotein convertase subtilisin/kexin type 9 is a psoriasis-susceptibility locus that is negatively related to IL36G.
Merleev A, Ji-Xu A, Toussi A, Tsoi LC, Le ST, Luxardi G, Xing X, Wasikowski R, Liakos W, Brüggen MC, Elder JT, Adamopoulos IE, Izumiya Y, Leal AR, Li Q, Kuzminykh NY, Kirane A, Marusina AI, Gudjonsson JE, Maverakis E. Merleev A, et al. JCI Insight. 2022 Aug 22;7(16):e141193. doi: 10.1172/jci.insight.141193. JCI Insight. 2022. PMID: 35862195 Free PMC article.
Intralesional interleukin-2 augmentation therapy in treatment-refractory melanoma.
Le ST, Ji-Xu A, Liakos W, Toussi AM, Cheng MY, Ma C, Wang EA, Wilken R, Boddu S, Downing L, Kao J, Davis JR, Monjazeb AM, Fung MA, Konia TH, Maverakis E, Kirane AR. Le ST, et al. Dermatol Ther. 2022 Nov;35(11):e15853. doi: 10.1111/dth.15853. Epub 2022 Oct 6. Dermatol Ther. 2022. PMID: 36151592 No abstract available.
42 results